Literature DB >> 10928761

Levels of collagen degradation products (telopeptides) in the tear film of patients with keratoconus.

J H Abalain1, H Dossou, J Colin, H H Floch.   

Abstract

PURPOSE: Levels of collagen degradation products (telopeptides) in the tear film of patients with keratoconus were measured to study the release of telopeptides in the tears.
METHODS: Tear samples were collected from 26 keratoconus patients and 36 age-similar human control subjects. Levels of telopeptides were quantified and compared between the two groups.
RESULTS: The telopeptide level in tears from keratoconus patients was 2.5-fold higher than in tears from the control group. The telopeptide concentration was age-dependent in both groups. In tears from young people, telopeptide level was 2-fold higher than in tears from the older people.
CONCLUSION: The tear film of patients with keratoconus contains higher levels of telopeptides than those of control subjects. Determination of telopeptide levels in tears could be useful for the follow-up of keratoconus development in patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928761     DOI: 10.1097/00003226-200007000-00014

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  10 in total

1.  Correlation between the COL4A3, MMP-9, and TIMP-1 polymorphisms and risk of keratoconus.

Authors:  Ramin Saravani; Davood Yari; Samira Saravani; Farzaneh Hasanian-Langroudi
Journal:  Jpn J Ophthalmol       Date:  2017-02-14       Impact factor: 2.447

Review 2.  Keratoconus: an inflammatory disorder?

Authors:  V Galvis; T Sherwin; A Tello; J Merayo; R Barrera; A Acera
Journal:  Eye (Lond)       Date:  2015-05-01       Impact factor: 3.775

3.  Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus.

Authors:  Mirna Stabuc-Silih; Metka Ravnik-Glavac; Damjan Glavac; Marko Hawlina; Mojca Strazisar
Journal:  Mol Vis       Date:  2009-12-20       Impact factor: 2.367

4.  Sequence variants in COL4A1 and COL4A2 genes in Ecuadorian families with keratoconus.

Authors:  Justyna A Karolak; Karolina Kulinska; Dorota M Nowak; Jose A Pitarque; Andrea Molinari; Malgorzata Rydzanicz; Bassem A Bejjani; Marzena Gajecka
Journal:  Mol Vis       Date:  2011-03-30       Impact factor: 2.367

5.  Tear proteomics in keratoconus.

Authors:  Catherine Pannebaker; Heather L Chandler; Jason J Nichols
Journal:  Mol Vis       Date:  2010-10-02       Impact factor: 2.367

6.  Alterations of tear mediators in patients with keratoconus after corneal crosslinking associate with corneal changes.

Authors:  Bence Lajos Kolozsvári; András Berta; Goran Petrovski; Kata Miháltz; Péter Gogolák; Eva Rajnavölgyi; Ziad Hassan; Péter Széles; Mariann Fodor
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

Review 7.  The Proteins of Keratoconus: a Literature Review Exploring Their Contribution to the Pathophysiology of the Disease.

Authors:  Eleftherios Loukovitis; Nikolaos Kozeis; Zisis Gatzioufas; Athina Kozei; Eleni Tsotridou; Maria Stoila; Spyros Koronis; Konstantinos Sfakianakis; Paris Tranos; Miltiadis Balidis; Zacharias Zachariadis; Dimitrios G Mikropoulos; George Anogeianakis; Andreas Katsanos; Anastasios G Konstas
Journal:  Adv Ther       Date:  2019-07-30       Impact factor: 3.845

8.  Changes in Corneal Morphology with Age in Asian Population: A Multicenter Study of 30,618 Cases.

Authors:  Ruijue Ma; Yuanyuan Liu; Lin Zhang; Jiaonan Ma; Tong Cui; Yulin Lei; Jie Hou; Zhengwei Shen; Xianglong Yi; Gang Liang; Yan Wang
Journal:  Adv Ther       Date:  2021-10-10       Impact factor: 3.845

9.  Assessing the role of systemic inflammation in the etiopathogenesis of advanced stage keratoconus.

Authors:  Ali H Reyhan; Ayşe Sevgi Karadağ; Şerife Şule Çınar
Journal:  Indian J Ophthalmol       Date:  2021-10       Impact factor: 1.848

10.  Identification of Key Genes and Molecular Pathways in Keratoconus: Integrating Text Mining and Bioinformatics Analysis.

Authors:  Di Hu; Zenan Lin; Junhong Jiang; Pan Li; Zhehuan Zhang; Chenhao Yang
Journal:  Biomed Res Int       Date:  2022-08-23       Impact factor: 3.246

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.